Warning! GuruFocus detected
1 Severe warning sign
with CABA.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Cabaletta Bio Inc
NAICS : 325412
SIC : 2834
ISIN : US12674W1099
Share Class Description:
CABA: Ordinary SharesCompare
Compare
Traded in other countries / regions
CABA.USACABA.Mexico Index Membership
Russell 2000Russell 3000Russell 2000 IPO Date
2019-10-25Description
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) has the potential to be applied across a broad range of autoimmune diseases.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 12.02 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.14 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -7.4 | |||||
| 3-Year EPS without NRI Growth Rate | -4.6 | |||||
| 3-Year FCF Growth Rate | -3.8 | |||||
| 3-Year Book Growth Rate | 3.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -17.19 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.73 | |||||
| 9-Day RSI | 31.16 | |||||
| 14-Day RSI | 34.37 | |||||
| 3-1 Month Momentum % | -21.18 | |||||
| 6-1 Month Momentum % | -57.63 | |||||
| 12-1 Month Momentum % | -89.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.11 | |||||
| Quick Ratio | 8.11 | |||||
| Cash Ratio | 8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -24.4 | |||||
| Shareholder Yield % | -13.37 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -52.47 | |||||
| ROA % | -47.82 | |||||
| ROIC % | -535.58 | |||||
| 3-Year ROIIC % | -285.74 | |||||
| ROC (Joel Greenblatt) % | -1156.4 | |||||
| ROCE % | -57.03 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.43 | |||||
| Price-to-Tangible-Book | 0.43 | |||||
| EV-to-EBIT | 0.8 | |||||
| EV-to-Forward-EBIT | -0.02 | |||||
| EV-to-EBITDA | 0.81 | |||||
| EV-to-Forward-EBITDA | -0.02 | |||||
| EV-to-FCF | 1.1 | |||||
| Price-to-Net-Current-Asset-Value | 0.49 | |||||
| Price-to-Net-Cash | 0.5 | |||||
| Earnings Yield (Greenblatt) % | 125 | |||||
| FCF Yield % | -110.31 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CABA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cabaletta Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.16 | ||
| Beta | 3.71 | ||
| 3-Year Sharpe Ratio | 0.45 | ||
| 3-Year Sortino Ratio | 1.25 | ||
| Volatility % | 54.01 | ||
| 14-Day RSI | 34.37 | ||
| 14-Day ATR ($) | 0.159804 | ||
| 20-Day SMA ($) | 1.746 | ||
| 12-1 Month Momentum % | -89.42 | ||
| 52-Week Range ($) | 1.4501 - 19.04 | ||
| Shares Outstanding (Mil) | 48.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cabaletta Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cabaletta Bio Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cabaletta Bio Inc Frequently Asked Questions
What is Cabaletta Bio Inc(CABA)'s stock price today?
The current price of CABA is $1.55. The 52 week high of CABA is $19.04 and 52 week low is $1.45.
When is next earnings date of Cabaletta Bio Inc(CABA)?
The next earnings date of Cabaletta Bio Inc(CABA) is 2025-05-15 Est..
Does Cabaletta Bio Inc(CABA) pay dividends? If so, how much?
Cabaletta Bio Inc(CABA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers